脂質異常症治療薬の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Dyslipidemia Drugs Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights

PART 05: An overview of dyslipidemia

PART 06: Pipeline analysis

PART 07: Market landscape
• Market overview
• Five forces analysis

PART 08: Market segmentation by drug class
• Statins
• Cholesterol absorption inhibitors
• Dyslipidemia injectables
• Others

PART 09: Geographical segmentation
• Dyslipidemia drugs market in Americas
• Dyslipidemia drugs market in EMEA
• Dyslipidemia drugs market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 12: Market trends
• Increasing use of statins
• Combination therapies
• Increased uptake of OTC drugs

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• Aegerion Pharmaceuticals
• AstraZeneca
• Merck
• Pfizer
• Sanofi
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Key customer segments
Exhibit 02: Overview of phase III pipeline molecules in global dyslipidemia drugs market
Exhibit 03: Pipeline analysis
Exhibit 04: Global dyslipidemia drugs market snapshot 2016
Exhibit 05: Global dyslipidemia drugs market 2016-2021 ($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Global dyslipidemia drugs market by drug class
Exhibit 08: Global statin market 2016-2021 ($ millions)
Exhibit 09: Global cholesterol absorption inhibitors market 2016-2021 ($ millions)
Exhibit 10: Global dyslipidemia injectables market 2016-2021 ($ millions)
Exhibit 11: Global dyslipidemia drugs market by geography 2016 and 2021
Exhibit 12: Dyslipidemia drugs market revenue by geography 2016-2021 ($ millions)
Exhibit 13: Market scenario in Americas
Exhibit 14: Dyslipidemia drugs market in Americas 2016-2021 ($ millions)
Exhibit 15: Market scenario in EMEA
Exhibit 16: Dyslipidemia drugs market in the EMEA 2016-2021 ($ millions)
Exhibit 17: Market scenario in APAC
Exhibit 18: Dyslipidemia drugs market in APAC 2016-2021 ($ millions)
Exhibit 19: Population aged 60 years and over: World and developed and developing regions (millions)
Exhibit 20: Impact of drivers
Exhibit 21: Impact of challenges
Exhibit 22: Competitive structure analysis of global dyslipidemia drugs market 2016
Exhibit 23: Competitive analysis of global dyslipidemia drugs market 2016
Exhibit 24: Market penetration of various players in global dyslipidemia drugs market 2016
Exhibit 25: Aegerion Pharmaceuticals: Key highlights
Exhibit 26: Aegerion Pharmaceuticals: Strength assessment
Exhibit 27: Aegerion Pharmaceuticals: Strategy assessment
Exhibit 28: Aegerion Pharmaceuticals: Opportunity assessment
Exhibit 29: AstraZeneca: Key highlights
Exhibit 30: AstraZeneca: Strength assessment
Exhibit 31: AstraZeneca: Strategy assessment
Exhibit 32: AstraZeneca: Opportunity assessment
Exhibit 33: Merck: Key highlights
Exhibit 34: Merck: Strength assessment
Exhibit 35: Merck: Strategy assessment
Exhibit 36: Merck: Opportunity assessment
Exhibit 37: Pfizer: Key highlights
Exhibit 38: Pfizer: Strength assessment
Exhibit 39: Pfizer: Strategy assessment
Exhibit 40: Pfizer: Opportunity assessment
Exhibit 41: Sanofi: Key highlights
Exhibit 42: Sanofi: Strength assessment
Exhibit 43: Sanofi: Strategy assessment
Exhibit 44: Sanofi: Opportunity assessment


【レポート販売概要】

■ タイトル:脂質異常症治療薬の世界市場2017-2021
■ 英文:Global Dyslipidemia Drugs Market 2017-2021
■ 発行日:2017年3月15日
■ 調査会社:Technavio
■ 商品コード:IRTNTR12273
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。